Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
By Shiladitya Sengupta, David A Eavarone, I. Capila, Ganlin Zhao, N. Watson, T. Kiziltepe, R. Sasisekharan. Nature, 2005
916 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Cancer Research, Cell Biology
View Paper: https://www.semanticscholar.org/paper/98edec4d621afae7972c733cdd7edcad1eb237cc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Cancer Research
- N. Bertrand
- O. Farokhzad
- Robert Langer
- Jun Wu
- Erkki Ruoslahti
- Xiaoyang Xu
- D. Richardson
- D. Kalinowski
In Cell Biology
- Robert Langer
- S. Mitragotri
- Joerg Lahann
- O. Farokhzad
- Hyun Ho Park
- K. Narayanan
- Dennis E. Discher
- A. Engler
Citations in the corpus
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. (2012, background): “that combines an antiangiogenic factor, combretastatin, with DOX [18].”
- Biodegradable luminescent porous silicon nanoparticles for in vivo applications (2009, background): “Many biodegradable polymeric nanoparticles that can encapsulate hydrophilic or hydrophobic drugs have been developed for in vivo therapeutic application”
- Biosynthesis, characterisation and anti-bacterial effect of plant-mediated silver nanoparticles using Artemisia nilagirica (2013, background): “Studies have shown that the size morphology stability and chemical–physical properties of the metal nanoparticles are strongly influenced by the experimental conditions, the kinetics of the interaction of metal ions with reducing agents, and the adsorption processes of stabilising agents with metal ”
- Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012, background): “synthesized a biphasic “nanocell” with a lipid layer containing combretastatin and a hydrophobic core containing PLGA-doxorubicin conjugates [193].”
- Bio-inspired, bioengineered and biomimetic drug delivery carriers (2011, background): “To co-deliver two antitumour drugs with distinct release kinetics, hybrid lipid and/or polymer 'nanocells' have been devised, which are based on the encapsulation of biodegradable polymer nanoparticles within lipid vesicle”
- Antifungal activity of silver nanoparticles synthesized using turnip leaf extract (Brassica rapa L.) against wood rotting pathogens (2014, background): “Moreover, the size, morphology, physical and chemical properties, and stability of the nanoparticles are dependent on the experimental conditions, the interaction of the reducing agent with metal ions, and adsorption of the stabilizing agent onto metal nanoparticles (Knoll and Keilmann 1999; Sengupt”
- Physical approaches to biomaterial design (2009, background): “A number of processes have been established for synthesis of core–shell particle”
- Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy. (2013, positive): “3 It had been reported that the delivery system loaded with a vascular shutdown combretastatin andanapoptosis-inducingdoxorubicin (DOX) significantly suppressed the growth of melanoma and lung carcinoma as compared to either single-agent regimen.(4) The codelivery strategy that utilized siRNA to sil”